This effect was significantly reversed with the treatment of CAT, which corroborates recent studies, where the ameliorative effect of CAT is linked to its ability to activate sirtuin-1 in mice with chronic skin disease [70], as well as rats with polycystic ovarian syndrome and colitis [71,72]. This evidence concerns the gene SIRT1 and polycystic ovary syndrome.